Publications by authors named "Eva-Maria Collnot"

Claim this Profile
D
Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
Fransisca Leonard, Srimeenakshi Srinivasan, Xuewu Liu, Eva-Maria Collnot, Mauro Ferrari

Eur J Pharm Biopharm· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 3D co-culture of three human cell lines to model the inflamed intestinal mucosa for safety testing of nanomaterials.
Julia Susewind, Cristiane de Souza Carvalho-Wodarz, Urska Repnik, Eva-Maria Collnot, Nicole Schneider-Daum

Nanotoxicology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
Hussain Ali, Benno Weigmann, Eva-Maria Collnot, Saeed Ahmad Khan, Maike Windbergs

Pharm Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Design of Experiment Study of Nanoprecipitation and Nano Spray Drying as Processes to Prepare PLGA Nano- and Microparticles with Defined Sizes and Size Distributions.
Christina Draheim, Francois de Crécy, Steffi Hansen, Eva-Maria Collnot, Claus-Michael Lehr

Pharm Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices.
David E Lefebvre, Koen Venema, Lourdes Gombau, Luis G Valerio, Jayadev Raju, Eva-Maria Collnot

Nanotoxicology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.
Jos G Bessems, George Loizou, Kannan Krishnan, Harvey J Clewell, Camilla Bernasconi, Eva-Maria Collnot

Regul Toxicol Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crossing biological barriers for advanced drug delivery.
Marc Schneider, Maike Windbergs, Nicole Daum, Brigitta Loretz, Eva-Maria Collnot

Eur J Pharm Biopharm· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.
Carsten Schmidt, Christian Lautenschlaeger, Eva-Maria Collnot, Michael Schumann, Christian Bojarski

J Control Release· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model.
Fransisca Leonard, Hussain Ali, Eva-Maria Collnot, Bart J Crielaard, Twan Lammers

ALTEX· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa.
Eva-Maria Collnot, Hussain Ali, Claus-Michael Lehr

J Control Release· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
Michael Linn, Eva-Maria Collnot, Dejan Djuric, Katja Hempel, Eric Fabian

Eur J Pharm Sci· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro.
Fransisca Leonard, Eva-Maria Collnot, Claus-Michael Lehr

Mol Pharm· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.
Eva-Maria Collnot, Christiane Baldes, Ulrich F Schaefer, Kevin J Edgar, Michael F Wempe

Mol Pharm· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
Eva-Maria Collnot, Christiane Baldes, Michael F Wempe, Reinhard Kappl, Jürgen Hüttermann

Mol Pharm· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o-.
Carsten Ehrhardt, Eva-Maria Collnot, Christiane Baldes, Ulrich Becker, Michael Laue

Cell Tissue Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.
Eva-Maria Collnot, Christiane Baldes, Michael F Wempe, John Hyatt, Lisa Navarro

J Control Release· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis